In today’s Recommendations for Industry, we discuss COVID-19 tests and the updated Risk Matrix (things are getting better). Read more below. Since the White House
In today’s Recommendations for Industry, we discuss COVID post-infection antiviral medication trials that are nearing completion. Read more below. Viruses limited by COVID-19 restrictions may
In today’s Recommendations for Industry, we discuss TAG’s perspective on FDA’s new vaccine booster EUA. Read More Here. Johnson and Johnson report that a second
In today’s Recommendations for Industry, we discuss answers to Flu vaccine questions. Read More below. The FDA has approved Pfizer’s COVID-19 booster for seniors and
In today’s Recommendations for Industry, we discuss the NRA’s update on OSHA’s discussion of the Biden Vaccine/Testing Mandate. Read more here. A recent study of
 In today’s Recommendations for Industry, we discuss President Biden’s COVID-19 employee vaccination/testing mandate and how TAG can help you prepare. Read more below. Both
In today’s Recommendations for Industry, we discuss a new COVID-19 treatment. Read more below. The most recent report from the American Academy of Pediatrics (AAP)
In today’s Recommendations for Industry, we look at the Mu variant and the Flu Vaccine. Read more below. S. COVID-19 cases have reached 40 million
In today’s Recommendations for Industry, we look at the Risk Matrix. Read more below. In Flu Season News: According to the WHO global flu update
